chrisvoncsefalvay/vaers-outcomes huggingface dataset:
4 day after HPV #1 Developed itchy arm a 1.5 cm ring of papules with slight blistering arm itching- no rash in center of >1 cm- Fanning gradually over 2 weeks.
Pt recvd 2 doses of Engerix-B on 11SEP91 & 11OCT91 & had false post HIV test; 3 times ELISA test performed & 3 times results were anti-HIV pos; Western blot test results were neg;
The arm was very sore for several weeks but was localized in the area of the shot. the pain did not radiate to the shoulder.
15 Y/O F syncopal event following vaccine. PT had LOC. Woke within 30-40 seconds, vomited x1. Was oriented x3. Treated w/ rest (supine, then sitting) and PO fluids. PT released to home w/in 45 mins. Dx: Vaso Vagal Syncope
Seriousness criteria other medically significant (OMIC). Initial report received on 11/8/06 from a health care professional. A male pt (demographics not reported) with a past medical history of Transverse myelitis, had received a dose of Adacel on 11/3/06. The lot number, route and site of administration were not reported. Two days post immunization, the pt complained of fever, chills, body aches, and had developed numbness and paralysis to the right side of his face. The pt self medicated with Ibuprofen. The pt was evaluated by a physician on an unspecified date. Per the reporter, it was unk if the pt had any illnesses at the time of the vaccination. At the time of this report, the recovery status of the pt was unk.
Possible flare of psoriatic arthritis; Possible serum sickness; This is a spontaneous report from a contactable consumer (patient).  A 42-year-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration, administered in Arm Left on 17Aug2021 16:45 (Lot Number: Fc3181) at age of 42-year-old as single dose for covid-19 immunisation.  Medical history included psoriatic arthropathy, known allergies sulfa. No Covid prior vaccination. Concomitant medications included sertraline hydrochloride (SERTRALINE); pantoprazole; famotidine.  No other vaccine in four weeks. The patient experienced Possible serum sickness, Severe myalgias, joint swelling, Possible flare of psoriatic arthritis on 17Aug2021 21:00. Adverse events resulted in [Doctor or other healthcare professional office/clinic visit]. Patient received NSAISA as treatment. Covid was not tested post vaccination. The outcome of events was recovering.  Follow-up attempts are completed. No further information is expected.
Body aches, chills (poss fever, though I didn't temp myself), low energy, felt almost like a low grade flu.  Onset: several hours after injection.  Duration: about 36-48 hours.  Outcome:  self-resolved without issue.
Vax received 5/8/07. Intussusception 6/21/07.  7/27/07 Vax record received which confirms RO lot & dose # as reported.  8/3/07 Received hospital medical records which reveal patient experienced abdominal pain, fussiness, decreased oral intake, fever & guaic positive stools.  Admitted 6/20-6/21/07.  No further blood noted.  Fever & abdominal pain resolved. FINAL DX: Abdominal pain, resolved; fever, resolved; guaiac positive stool.   8/17/07 Received hospital medical records as requested by PCP.  Confirms that patient did not have IS & did not received BE as initially reported by parent to PCP.
Parent mistook DOB and thought the child was 12. DOB and age on the form was 12. Discovered when system merged the two records and the true DOB was the primary record indicating age 11 at time of vaccine.
This spontaneous report as received from a register nurse refers to a 6 months infant, of unknown gender. Medical history and concurrent conditions were not reported. On 12-FEB-2014, the patient was vaccinated with dose 2 of ROTATEQ lot #J007283; expiration date: 27-SEP-2014 (dose, strength and route were not reported). Secondary and concomitant therapies were not reported. Nurse called and stated that improperly stored ROTATEQ was administered to patient. No adverse effects reported. The nurse reported that vaccine dose received by patient was a vaccine improperly stored as follows: On 13-JAN-2014, ROTATEQ was stored outside of recommended temperatures for 2 hours (2 pm - 4 pm) the temperature recorded was 50 degrees F. On 18-JAN-2014, ROTATEQ was stored outside of recommended temperatures for 2 hours (2 pm - 4 pm) the temperature recorded was 49.1 degrees F. On 10-FEB-2014, ROTATEQ was stored outside of recommended temperatures for 6 hours (12 pm - 6 pm) the temperature recorded was 51.8 degrees F. On 16-FEB-2014, ROTATEQ was stored outside of recommended temperatures for 5 hours (12 pm - 5 pm) the temperature recorded was 51.8 degrees F. On 22-FEB-2014, ROTATEQ was stored outside of recommended temperatures for 4 hours (2 pm - 6 pm) the temperature recorded was 52.7 degrees F. On 09-MAR-2014, ROTATEQ was stored outside of recommended temperatures for 2 hours (12 pm - 10 pm) the temperature recorded was 55.4 degrees F. On 15-MAR-2014, ROTATEQ was stored outside of recommended temperatures for 6 hours (8 am - 2 pm) the temperature recorded was 50 degrees F. On 16-MAR-2014, ROTATEQ was stored outside of recommended temperatures for 20 hours (2 am - 10 pm) the temperature recorded was 64.4 degrees F. On 17-MAR-2014, ROTATEQ the temperature reading on the morning was 64.8 degrees F. The total of hours stored outside of recommended temperatures was 55 hours. This is one of several reports from the same reporter. Additional information has been requested.
Headache within 10 minutes of injection. Dizziness, developed SOB and was advised by EMS to go to hospital. C/O SOB at 7 pm - no other signs of allergy - EMS took to hosp.
Excessive yawning and watering eyes started immediately, but otherwise fine.  30 mins after vaccine started with ?tickle in throat? and coughing.  Within minutes wheezing and immediately left for urgent care. Wheezing was increasingly pronounced and couldn?t breathe. Itchy ears and throat, swelling of mouth/lips and felt throat closing. Husband pulled over to administer epi shot (used inhaler multiple times prior with no relief)   At urgent care received steroids and benedryl through IV and oxygen. Rushed immediately  to hospital by ambulance where I received additional meds and albuterol breathing treatment
Date and time of vaccination: (list both if they received both shots):   2nd dose received at 0900h on 2/6/2021 Brand and lot of vaccine:   unknown  Fever, body aches, stomach pain
Chest tightness, left side jaw, shoulder, arm pain, onset 3 days after vaccination and still persisting after 13 days of vaccination. It subsided from how it started, but still there. Doc did tests and nothing seems to be wrong.
Day one, about 6 hours after vaccine, extreme tiredness, slur speech, slow movement, vertigo,  sore arm.  Day two, extreme tiredness, headache, nausea , sore arm.
had all the vaccines from Pfizer; had all the vaccines from Pfizer; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient. Other Case identifier(s): US-PFIZER INC-202200531233.  An 80-year-old male patient received BNT162b2 (BNT162B2), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Heart Patient" (ongoing); "Covid" (unspecified if ongoing), notes: coughing and feeling week because of the Covid. The patient took concomitant medications.  The following information was reported: DRUG INEFFECTIVE (medically significant), SUSPECTED COVID-19 (medically significant), outcome "unknown" and all described as "had all the vaccines from Pfizer".  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
This case was reported by a consumer via call center representative and described the occurrence of stroke in a 70-year-old female patient who received SHINGRIX for prophylaxis. On 30th May 2018, the patient received the 1st dose of SHINGRIX (intramuscular) .5 ml. On 31st May 2018, 1 days after receiving SHINGRIX, the patient experienced headache, chills and feeling unwell. On 1st June 2018, the patient experienced stroke (serious criteria GSK medically significant) and anxiety. On an unknown date, the outcome of the stroke, headache, chills and feeling unwell were unknown and the outcome of the anxiety was not recovered/not resolved. It was unknown if the reporter considered the stroke, headache, anxiety, chills and feeling unwell to be related to SHINGRIX. Additional details were provided as follows: This case was transferred from GlaxoSmithKline (GSK) Patient Assistance Foundation. The next day after vaccination, she did not feel well. She woke up with headache and chills. She took some medication and went to work. On Friday at 3 PM, 2 days after receiving SHINGRIX, the patient suffered a small stroke and someone told her that SHINGRIX could cause strokes. The patient's physician was baffled by the incident. The patient was left with anxiety from having the stroke. The patient said that there was no reason why she should have had a stroke as she was neither diabetic, nor overweight. She had no blood pressure problems. There was no reason why the patient had a stroke. Further information was not able to collect from the patient. The reporter stated that, she was calling to get an answer and she wanted to know any case of strokes had been reported previously. The patient's husband was a pharmacist, he clarified that he did not administer the vaccine and the call was transferred to medical information (MI) for questions on stroke as an adverse event. The patient provided contact details of the physician.
arm sore; This case was reported by a pharmacist via call center representative and described the occurrence of pain in arm in a 62-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced pain in arm. On an unknown date, the outcome of the pain in arm was recovered/resolved.   It was unknown if the reporter considered the pain in arm to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. For tolerability of 2nd dose, refer case US2019117673.
- w/in 15 min nausea and slight vertigo.  Soreness in left arm.   - w/in 45 min nausea & vertigo went away, soreness travelled into left side of neck/head & jar. Sinus pressure and then difficulty swallowing.   - w/1n 60 min itching (no hives) and periodic difficulty swallowing - w/in120 min all symptoms dissipated except for slight soreness in left arm.
Rash, Tachycardia, reported itchy mouth and throat, and body no rash visualized Narrative: Mild-Moderate B/P was 155/160 pulse 85 100% on room air. reported itchiness all over body including throat and mouth. RN gave 50MG IM Benadryl to Right deltoid. EMS notified and escorted to be monitored further in the Emergency Department.
I had headache, nausea, difficulty breathing, fatigue and fever. These symptoms lasted about 6 weeks. I went to ER, and they did blood work, COVID-19 test, EKG, and chest X-ray. My COVID-19 test came back positive. About 4 weeks later, I went to my primary care doctor because I still had symptoms.
A small amount of blood coming from the vaccination site caused the patient to feel dizzy and get tunnel vision. Patient may have lost consciousness but only for a second or two. Appeared diaphoretic, pale and unsteady. Was assisted to supine position and was responsive at that time with improved color, BP 128/82, HR 55, O2 98 within 5 minutes. Observed in supine for 30 minutes, re-evaluated vital signs at 15 minutes past laying supine with BP 122/76, HR 66, O2 98. Took orthostatic BP at 30 minutes with no drop in blood pressure.
Information has been received from a registered nurse concerning a 66 year old female who on 08-OCT-2008 was vaccinated with PNEUMOVAX vaccine (lot # 660685/0619X) (dose and site was not reported). The patient was vaccinated with FLUZONE vaccine (unspecified) on the same day. On 10-OCT-2008 the patient experienced an injection site reaction: a golf ball site area that was red and swollen, fever and was vomiting. The patient sought medical attention on unspecified date. At the time of reporting the patient was recovering. This is one of several reports from the same source. Follow up information was received from a registered nurse. It was reported the patient who was a female with hypertension, gastroesophageal reflux disease and hyperlipidaemia and a history of atrial fibrillation on 08-OCT-2008 at 10:00am was vaccinated intramuscularly into the left deltoid with a first dose of PNEUMOVAX vaccine. Concomitant therapy included a fourth dose of FLUZONE vaccine, lot # U2811AA which was vaccinated intramuscularly into the left deltoid on 08-OCT-2008 at 10:01 am. On 10-OCT-2008 the patient presented to the office with complaints of left arm redness and pain in upper deltoid region, "area 2" wide x 3" length". The patient was advised TYLENOL, ice packs for comfort measures. On unknown date, the patient recovered. No further information is available
Information has been received from an infectious disease physician and a nurse concerning a 31 month old male with "no unusual medical history" and who was believed to be immunocompetent who in approximately 06/01, at one year of age, was vaccinated with a dose of varicella virus vaccine live. The physician indicated that the pt experienced two episodes of shingles. The first episode of shingles (also reported as herpes zoster type rash) occurred in 01/03 (also reported as occurring one year and four months after vaccination). It was described as a moderate case on the left face and left scalp with left eye swelling.  This episode required hospitalization. It resolved in five days without medication. The second episode of shingles (also reported as herpes zoster type rash) started "five days ago" on 04/03/03 and was described as mild and involved the shoulders and left chest. The pt had a culture at this point which was negative. A lymphocyte test was negative on 04/08/03 and IgA, IgM, and IgE were normal.  Unspecified medical attention was sought. It was noted that nothing was prescribed.  The child subsequently recovered from this episode. The nurse indicated that the pt's mother had reported another episode starting on 06/10/03 where the pt had the same type of rash on his back. It was also reported that this was a "shingles outbreak." The child did not have a vesicular lesions with these rashes. The reporter indicated that she would check with the pt's mother to see if a dried lesion sample could be obtained.  Additional information has been requested.
Information has been received from a registered nurse referring to an unspecified number of patients of unknown age and gender. No pertinent or historical conditions were reported. On unknown dates, the patients were vaccinated with improperly stored ZOSTAVAX (route, dose, Lot# and expiration date not reported). No adverse effect had been reported. This is one of two reports received from the same reporter. Additional information has been requested.
10 days after vaccine patient developed the measle rash, low grade fever. no coryza. Rash began on head and spread cephalocaudal.
Swollen, red, itchy, and painful at injection site.  Affected area roughly 6 inches by 3 inches.
Patient had a near syncopal event approximately 5 minutes after getting the vaccine. He became shaky, weak, diaphoretic and felt like passing out. He was placed on the exam table and approximately 5 minutes later, he was feeling much better and was able to walk out of the clinic feeling like normal.
Rash on the injection site; redness; Itchiness; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE RASH (Rash on the injection site), VACCINATION SITE ERYTHEMA (redness) and VACCINATION SITE PRURITUS (Itchiness) in a 94-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011J20A) for COVID-19 vaccination.     No medical history information was reported.     On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Jan-2021, the patient experienced VACCINATION SITE RASH (Rash on the injection site), VACCINATION SITE ERYTHEMA (redness) and VACCINATION SITE PRURITUS (Itchiness). At the time of the report, VACCINATION SITE RASH (Rash on the injection site), VACCINATION SITE ERYTHEMA (redness) and VACCINATION SITE PRURITUS (Itchiness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided.  No treatment details were reported. This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 20-Jan-2021 and was forwarded to Moderna on 23-Jan-2021.    This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE RASH (Rash on the injection site), VACCINATION SITE ERYTHEMA (redness) and VACCINATION SITE PRURITUS (Itchiness) in a 94-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011J20A) for COVID-19 vaccination.     No medical history information was reported.     On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Jan-2021, the patient experienced VACCINATION SITE RASH (Rash on the injection site), VACCINATION SITE ERYTHEMA (redness) and VACCINATION SITE PRURITUS (Itchiness). At the time of the report, VACCINATION SITE RASH (Rash on the injection site), VACCINATION SITE ERYTHEMA (redness) and VACCINATION SITE PRURITUS (Itchiness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided.  No treatment details were reported.
chills; fever; rash all over body; fatigue; loss of appetite; A spontaneous report was received from a 52-years-old  female patient concerning herself who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events chills, fatigue, loss of appetite, fever, rash full body.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On 3 Jan 2021, prior to the onset of the events the patient received their first of two planned doses of mRNA-1273 (lot/batch: 012L20A) intramuscularly  at an unknown anatomical location for prophylaxis of COVID-19 infection.  On 3 Feb 2021, prior to the onset of the events the patient received their second of two planned doses of mRNA-1273 (lot/batch: 012M20A) intramuscularly at an unknown anatomical location for prophylaxis of COVID-19 infection.  On 3 Feb 2021, the patient experienced the events fatigue, loss of appetite, fever and rash full body.  On 4 Feb 2021, the patient experienced the event chills .   Treatment details included Tylenol.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of events chills, fatigue,loss of appetite, fever and rash full body was unknown.; Sender's Comments: Very limited information regarding this events has been provided at this time. Further information has been requested. Company assessed the events to be unlikely related to company product.
Patient presented to the vaccination site on 10/26/21. The client notified RN that he received COVID vaccine on 4/28/21. RN submitted a medical consult via text message to Vaccine Operations Leads, requesting to proceed with the COVID vaccine Janssen first dose. Per CDC guidance, approval to proceed with COVID vaccine Janssen first dose was obtained from medical consult team, Vaccine Operations Lead via text message. Client received COVID vaccine Janssen first dose Lot# 1822809 on 10/26/2021. The client did not report any symptoms during the observation period. The client left the vaccination site at 1045.
**Uncertain if it this is related to the vaccine** On 3/14/21, a week after vaccine was administered, I had a fast food meal I've had several times before. Around 30-40 minutes later, I began experiencing a reaction I'm not prone to.  I had severe heartburn throughout most of the night and my lips began to swell which made me mistakenly assume I have had a cardiac event. While in the morning the pain had subsided, the numbness in the lips hadn't and I went to the ER thinking it might've been a heart issue. No cardiac condition was noted at the hospital which leads me to believe I may have had a severe allergic reaction to foods or environmentals I've never had reactions to.
She got the vaccine, she had no effects, and no reaction whatsoever. The husband had no side effects either.   On 3/16/21 they were on their way to go to bed and the bedroom is upstairs and she was fine, she was in the bedroom getting ready for bed, and her husband followed 15 minutes later and when he got upstairs she was sitting in a chair next to the bed, and he noticed that when he spoke with her that she did not speak clearly back, and was very low tone, not much loudness to her speech.  He didn't think much about it, and he talked with her again and noticed that she seemed to be having some difficulty talking, but he could understand what she was saying if he paid close attention.  He then realized that something was wrong, and asked her how she felt and she said she felt strange.  She was trying to take a pair of socks off and could not reach them.  She tried to lift her leg to put one knee over the other for her to remove them and was not able to do that.  He helped her take the socks off, she wanted to put some cream on her foot and was not able to do so, which is her usual routine.  He put that on her foot while he was talking to her, and her speech was different than it was earlier.  She was wearing a turtle neck shirt and was not able to take it off to get dressed for bed.  Her husband assisted in dressing her to get ready for bed.  He was thinking that she may have been having a mini-stroke.  She tried to get up from the chair and was not able to get up on her own.  He went to try to help her to lift her and it was hard.  When she did get her bottom up off the chair she stayed in a bent position and was not able to stand up.  He put her back down on the chair and tried some more times, and ultimately able to get up and he was able to get her into the bed (the chair was next to the bed).  She could sit on the edge of the bed, but was not able to move her legs on her own to get into the bed.  He struggled to get her in the bed and was not in a mood to talk and just leaned over on one side to try to go to sleep.  He told her he was going to get the walker in the basement for her to use.  He brought up the walker and put in by the bed, and informed her that it was there, and reached to see where it was in the event that she needed to use it through the night.  She did get up around 3:15 this morning to use the bathroom and her husband asked if she needed assistance, and she said that she was able to get up and go to the bathroom, and moved her legs just slow and was able to use the walker.  She was feeling much better at that time.  She got up one more time during the night and was not in need of the walker and was back to bed.  This morning when they got up at 8:00 Am and she was back to her normal self.   She came down the steps and was like nothing had ever happened.  They called her son who works in the hospital and he told them to call us to see if there were any other people that had the same reaction.    She stated while he was giving me this information that she did not recall a lot of the events that he was telling me.
Covid toes. Severe sores on toes and getting infected!!!Lips feel like deep deep cuts. Severe bleeding in lips. Nausea. You should take this off the market and read the medical insert and warn people of these bad side effects.
Overnight chills, fever (100.6) headache and dizziness.  Headache mildly persists, fever is going down.  Re Item 20, I am getting better.